What is the ticker symbol for City Therapeutics?

City Therapeutics trades under the ticker CTY on NASDAQ.

What sector does City Therapeutics operate in?

City Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze CTY in a portfolio?

PortView shows CTY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

City Therapeutics (CTY) Stock Analysis

NASDAQHealthcareBiotechnology

$21.65+3.79%

1-year price historyRange $20.43 – $22.72

52-week range$21.65

$19.75$23.88

Track CTY in your portfolio for free · Portfolio tracker

What City Therapeutics does

City Therapeutics, Inc. is a biotechnology company specializing in next-generation RNA interference (RNAi) therapeutics. The company is based in Cambridge, MA. The company engineers potent, specific, and durable RNAi trigger molecules combined with precision targeting ligands to deliver siRNAs beyond the liver to tissues such as ocular and central nervous system targets. Its R&D pipeline includes programs addressing thromboembolic diseases (targeting Factor XI), Stargardt disease (targeting RBP4), and other hepatic, ocular, and CNS conditions. Lead candidates include CITY-FXI, designed to prevent blood clots with reduced bleeding risk, and CITY-RBP4, aimed at slowing or halting vision loss in Stargardt disease. The company was founded by Ari Nowacek, John M. Maraganore. Andrew C. Orth has been the CEO of the company since 2025.

Key metrics

Market cap

$210.49M

P/E (TTM)

-8.56

EPS (TTM)

$-2.53

Beta

0.00

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$21.04

200-day avg

$21.04

52-week high

$23.88

52-week low

$19.75

CEO

Andrew C. Orth

ETFs linked to CTY

Broad-market and Healthcare sector ETFs an investor holding City Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how CTY fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze CTY in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for City Therapeutics?: City Therapeutics trades under the ticker CTY on NASDAQ.
Which exchange is CTY listed on?: CTY is listed on NASDAQ.
What sector does City Therapeutics operate in?: City Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze CTY in a portfolio?: PortView shows CTY's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.